Resultados de procura - Pieters, Rob
- Mostrando 1 - 20 Resultados de 133
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients por Pieters, Rob, Huismans, Dieuwke R., Loonen, Anne H., Hählen, Karel, Veerman, Anjo J. P.
Publicado 1991Text -
7
Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia por Buitenkamp, Trudy D., Mathôt, Ron A.A., de Haas, Valerie, Pieters, Rob, Zwaan, C. Michel
Publicado 2010Text -
8
-
9
Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo por Kerstjens, Mark, Pinhancos, Sandra S., Castro, Patricia Garrido, Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.
Publicado 2018Text -
10
Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia por Kerstjens, Mark, Garrido Castro, Patricia, Pinhanços, Sandra S., Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.
Publicado 2021Text -
11
Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements por Homminga, Irene, Vuerhard, Maartje J., Langerak, Anton W., Buijs-Gladdines, Jessica, Pieters, Rob, Meijerink, Jules P.P.
Publicado 2012Text -
12
MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations por Kerstjens, Mark, Driessen, Emma M.C., Willekes, Merel, Pinhanços, Sandra S., Schneider, Pauline, Pieters, Rob, Stam, Ronald W.
Publicado 2016Text -
13
-
14
Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study por van der Linde, Margrietha, van Leeuwen, Nikki, Eijkenaar, Frank, Rijneveld, Anita W., Pieters, Rob, Karim-Kos, Henrike E.
Publicado 2022Text -
15
-
16
-
17
High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia por Jerchel, Isabel S., Chatzivasileiou, Danai, Hoogkamer, Alex Q., Boer, Judith M., Beverloo, H. Berna, Pieters, Rob, den Boer, Monique L.
Publicado 2018Text -
18
Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia por van Atteveld, Jenneke E, de Winter, Demi TC, Pieters, Rob, Neggers, Sebastian JCMM, van den Heuvel-Eibrink, Marry M
Publicado 2021Text -
19
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase por Pieters, Rob, Hunger, Stephen P, Boos, Joachim, Rizzari, Carmelo, Silverman, Lewis, Baruchel, Andre, Goekbuget, Nicola, Schrappe, Martin, Pui, Ching-Hon
Publicado 2010Text -
20
Alterations in Epithelial and Mesenchymal Intestinal Gene Expression During Doxorubicin-Induced Mucositis in Mice por de Koning, Barbara A E, Lindenbergh-Kortleve, Dicky J., Pieters, Rob, Büller, Hans A., Renes, Ingrid B., Einerhand, Alexandra W. C.
Publicado 2007Text